No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
TPF
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
cisplatin + paclitaxel
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
afatinib
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
capecitabine
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
methotrexate
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
5-fluorouracil
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
docetaxel
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
paclitaxel
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
carboplatin
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
pembrolizumab
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
cetuximab
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
carboplatin + paclitaxel
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
cisplatin + docetaxel
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
nivolumab
Sensitive: A2 - Guideline
|
PD-L1 expression
PD-L1 expression
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
pembrolizumab
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
cisplatin + paclitaxel + 5-fluorouracil
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
cisplatin + 5-fluorouracil
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
5-fluorouracil + hydroxyurea
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
carboplatin + 5-fluorouracil
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
cisplatin
Sensitive: A2 - Guideline
|
ITGAE overexpression
ITGAE overexpression
|
Oropharyngeal Cancer
Oropharyngeal Cancer
|
cetuximab
Sensitive: C3 – Early Trials
|
